Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

04 December 2012: Basic Research  

Extracellular matrix in deoxycholic acid decellularized aortic heart valves

Oliver Bloch ABCDEF , Wilhelm Erdbrügger ABCDE , Wolfgang Völker BCD , Alexander Schenk BCD , Steffen Posner BCDEF , Wolfgang Konertz ACDEFG , Pascal M. Dohmen ACDEFG

DOI: 10.12659/MSM.883618

Med Sci Monit 2012; 18(12): BR487-492

0 Comments

Background

Decellularization of heart valves is a promising approach to overcome the limitations associated with conventional manufacturing techniques of bioprostheses. During the last years xenografts prepared with methods of decellularization have been used clinically [1–5]. However, there were also drawbacks with some of these products, mostly related to incomplete cell removal [6]. Nevertheless promising results have been achieved with deoxycholic acid decellularized pulmonary heart valves. These xenografts showed growth and remodelling of the valves in the juvenile sheep [1,7]. Furthermore these valves show excellent clinical performance for now up to 10 years [8–10] and also lack immunological response by the patient [11]. Encouraged by these results, the focus has now been set on the influence of the deoxycholic acid treatment on the preservation of the interstitial fine structure of aortic valves, in which proteoglycans (PG) represent a major component.

PGs are involved in the organization, hydration, electrolyte regulation, cell surface interaction, antithrombogenicity, prevention of calcification, and in the binding of growth factors [12–14]. Therefore, they might also play a significant role in mechanisms related to remodelling and growth of decellularized valves in patients. Due to their molecular composition PGs are ideal candidates for ultracytochemical investigations by electron microscopy. They contain polysulfated glycosaminoglycan (GAG) side chains which are covalently attached to a filamentous core protein. These GAGs interact with tetracationic dyes such as cuprolinic blue or cupromeronic blue (CMB) [15,16]. Both dyes offer a number of sophisticated methods for electron microscopic detection and characterization of PGs in situ. In each case, electron contrast must be enhanced by Na2WO4. PG molecules then appear as long-shaped precipitates and can be discriminated by criteria like size, location, critical electrolyte concentration and their susceptibility towards GAG-degrading enzymes as shown previously in arterial and valve tissues [15,17–20].

In the present electron microscopic study we have focussed our interest on the integrity of the interstitial compartments, in which decorin as a collagen-associated PG and versican in the soluble matrix are dominating [21,22]. Decorin is a small PG with one dermatan-sulphate (DS) GAG side chain. DS controls the fibrillogenesis and is responsible for the interspaces between collagenfibrills. Versican is one of the larger PGs and contains multiple GAG side chains, most of them being chrondroitin-sulphate (CS). CS possesses the ability to bind large amounts of water to build a gel like layer. This layer plays an important role in the tissue and supports to resist compressive deformations and to absorb loads. Combined DS and CS represent 90% of the total GAG content in heart valves [17]. Decellularization experiments with the aim to produce low antigenetic bioscaffolds suitable as xenografts must take care of this three-dimensional extracellular network in which these different types of PG are present and specifically located. When applied alone, the CMB method excludes collagen and elastic fibers to be stained intensively. Therefore, an overall staining of PG-related structures was applied also by extending CMB staining in some specimens and by using OsO4/thiocarbohydrazide/OsO4 (OTO) before dehydration and embedding of the tissues in epoxy resin [20].

Material and Methods

PREPARATION OF HEART VALVES:

Porcine hearts were obtained from a local slaughterhouse. The aortic valves were dissected and stored at 4°C in antibiotic solution (200 U/ml Penicillin, 200 mg/ml Streptomycin and 10 μg/ml Amphotericin B). Incubation with 1% deoxycholic acid (sodium salt, Fluka, Deisenhofen) was performed for 24 h and for 48 h at 37°C in physiological saline (PBS). Deoxycholic acid and products of lysis were removed afterwards by washing the specimens several times with PBS alone at room temperature, as described earlier [1]. As reference tissues, aortic valves were prepared and stored at 4°C in antibiotic solution without deoxycholic acid treatment. For ultracytochemical processing, small tissue samples were chemically fixed with 2.5% glutaraldehyde.

PROTEIN QUANTIFICATION:

In parallel to our ultrastructural investigations immune assays were used to quantify the loss of cellular proteins by deoxycholic acid treatment compared to native tissue expressed as percent of residual smooth muscle cell-(SMC)-α-actin and of soluble total protein. SMC-α-actin is present in most valvular cells and is therefore a adequate marker for cells in heart valves. Treated and untreated aortic tissues were homogenized in PBS (0.5 g/ml, pH 7.4) with an Ultra-Turrax (Jahnke & Kunkel, Germany). The homogenates were centrifuged at 2000 × g for 10 min. The supernatant was collected and kept at −80°C until use. Protein determinations were performed according to Bradford [23].

Sandwich ELISA was initiated by binding of anti-SMC-α-actin (clone E184, Epitomics, CA, USA, 1:500) for 120 min to anti-mouse IgG coated microtiter plates (Pierce, IL, USA). Then 250 μl heart valve samples were added and incubated for 120 min. After washings with PBS 4 μg/ml of second, different primary anti-SMC-α-actin antibody (clone AC-40, Sigma, Deisenhofen, Germany, 1:500) was added and incubation continued for 120 min. Then primary antibodies were labelled with a biotinylated anti-mouse IgG secondary antibody (Rockland, PA, USA, 100 μl, 1:10.000) followed by streptavidin-horseradish-peroxidase (HRP, Rockland, 100 μl, 1:10.000). A colour reaction was obtained with peroxidase reagent after 25 min (100 μl, TMB: 3.5′,5.5′-tetramethylbenzidine, Pierce). The reaction was terminated with TMB stop reagent (100 μl, Sigma). Optical density was measured at 450 nm with 620 nm as reference using an Anthos Labtec HATII plate reader (Anthos, Austria). Incubation steps with antibodies, samples or enzymes were followed by washings with PBS (3×250 μl each). All samples were determined in triplicate. Standard curves were estimated with supernatant of untreated aortic valves covering two fold dilutions of 15 steps. α-actin content of treated valves were estimated from the standard curves as percentage of the α-actin content of untreated valves.

GLYCOSAMINOGLYCAN DETERMINATION:

For the determination of the GAG content in the tissues the method of Farndale was used [24]. Briefly, the tissues were homogenated first and interfering proteins were digested for 16 h at 60°C with papain. Following digestion iodoacetic acid was added to a final concentration of 10 mM and the sample was filled up to a final volume of 5 ml with 50 mM TRIS/HCL (pH 8.0). For further purification of the GAGs the samples were treated twice with ethanol to precipitate the GAGs. Following solubilization the samples were divided each into three tubes. The first was digested with chondroitinase ABC, the second with chondroitinase AC and to the third solely buffer was added. Following 30 minutes of incubation at 37°C the samples were mixed with the colour reagent and the resulting optical density was determined at 540 nm. The chondroitinase ABC digests chrondroitin- and dermatan-sulphate whereas chondroitinase AC solely digests chrondroitin-sulphate. For the chondroitin-sulphate the reduction achieved by the chondroitinase AC digestion compared to buffer alone was calculated. For the determination of the dermatan-sulphate the reduction achieved by the chondroitinase ABC digestion was calculated in relation to the chondroitinase AC digestion. With previously maintained standard curves the concentrations of the samples were estimated.

ULTRAHISTOCHEMICAL PROCESSING:

Treated and untreated tissue samples of aortic heart valves were fixed with 2.5% glutaraldehyde. Cupromeronic blue (Seikagaku, Japan) staining was done in acetate buffer at pH 5.6 and counterstaining was performed with Na2WO4 according to Rothenburger et al. [18]. In parallel to CMB staining alone, CMB staining was extended with a sequence of OsO4/thio-carbo-hydrazide/OsO4 (OTO) as described [19]. After washing, specimens were dehydrated in a graded series of ethanol and embedded in epoxy resin for ultra thin sectioning. They were digitally photographed in a transmission electron microscope (Philips EM 201, FEI, Germany) using imaging plates (DITABIS, Aschaffenburg, Germany).

DATA ANALYSIS:

Data given are mean and standard deviation (SD) of the number of independent experiments indicated (n). GraphPad Prism (GraphPad Inc., CA, USA) was used to analyse ELISA experiments by curve fitting. The evaluation and standard curves for the biochemical investigations of chondroitin- and dermatan-sulphate were performed with GraphPad Prism as well.

Results

For the preparation of bioscaffolds from porcine aortic heart valves a protocol employing deoxycholic acid has been used to remove all cells. The effects of deoxycholic acid lysis were estimated after 24 h and 48 h of incubation with regard to protein and GAG content and, by electron microscopy, with regard to the preservation of the topography of the PGs in the interstitial space.

As shown by ELISA the residual content of smooth muscle cell (SMC) α-actin in decellularized valves was 0.96%±0.71 (n=3). The low amount of remaining α-actin indicated a high efficiency of cellular lysis. After a 24 h deoxycholic acid treatment the total soluble protein content representing intra and extracellular protein (6.68%±2.0, n=3) did not decline further even when the incubation time of the treatment was extended to 48 h.

Similar results were obtained with regard to the CS and DS content in the tissues investigated. Here we achieved a considerable higher GAG concentration in decellularized compared to untreated tissues. The measured CS concentration was app. 1.2±0.5 mg CS/g fresh weight (fw) in decellularized tissues and 0.6±0.2 mg CS/g fw in native tissues. The DS concentration in the treated tissues was 0.5±0.3 mg DS/g fw and in native tissues 0.3±0.1 mg DS/g fw.

These findings were confirmed by electron microscopic observations. CMB-OTO overall staining showed disruption of the nuclear envelope and of the cytoplasmic membrane as well as the release of nuclear filaments through the cytoplasm into the proximity of the cells (Figure 1). Cytosceletal filaments were not visible any more, the shape of the cells appeared rough, and their basement membrane was largely removed.

The influence of cell lysis and protein extraction by deoxycholic acid on the integrity of the PG-rich network in the interstitial space was investigated in valve tissues exclusively stained with CMB (n=3). These specimens revealed faintly stained elastic layers and collagen bundles but intensively and more clearly defined PG-CMB precipitates (Figure 2). We observed small PG-CMB precipitates aligned along collagen-fibrils formerly characterized as dermatansulfate/chondroitin-4-sulfate PGs (decorin), or at elastic fibers as well as on the cell surface, as heparansulfate-rich ones [15,17]. Large PG-CMB precipitates about 200 nm in length were located outside the collagen-fibrils in an area called soluble matrix. These PGs were described as chondroitin-6-sulfate-rich ones (versican). When compared with controls high magnification electron micrographs revealed that the molecular network of these different types of PG was not disrupted by the deoxycholic acid treatments, neither after 24 h nor after 48 h of incubation (Figure 2).

Discussion

In the present study a similar method as recently described for porcine pulmonary heart valves has been used for decellularization of porcine aortic heart valves applying deoxycholic acid [1]. The focus of this study was set on biochemical and electron microscopic investigations of aortic valve tissue following deoxycholic acid treatment, with special emphasis to PGs and their GAG side chains. As a major component of the interstitial space PGs are essential for maintaining physical and physiological properties of arterial tissue and, therefore, must resist deoxycholic acid induced destruction of their extracellular network to be clinically applicable. The biochemical investigation of the tissues revealed an even higher concentration of relevant GAGs following decellularization. This increase can be most likely be explained by the reduction of the specific weight of the tissue by decellularization due to the considerable reduction of cellular components like proteins, i.e. the protein content of treated valves was reduced by 93% compared to native valves. Alternatively it is also possible that the assay is being affected by cellular components in native tissues following papain digestion. Thus, some GAGs, which are associated with cells, might be lost during purification. Nevertheless these results underline that there is no overall decrease in GAG concentration following decellularization of the tissue. The present data are consistent with previous investigations of Grand-Allen et al who estimated a total GAG content of 0.69 mg/g in aortic valves [25], which is close to the GAG content achieved in this study. The preservation of GAGs following decellularisation could be confirmed by electron micrographs showing PGs and their associated extracellular structure in situ to be intact after 48 h deoxycholic acid treatment. Prior to the ultra-histological examinations the effectiveness of lysis and the loss of cellular components was checked by estimating residual SMC-α-actin and total protein content. As the total protein content remained stable and did not decline further in the prolonged deoxycholic acid treatment of 48 h there is evidence that the soluble cellular proteins were sufficiently and quantitatively extracted. SMC-α-actin is presumably a suitable indicator for effectiveness of decellularisation of vascular segments of the valves, since it is a contractile protein which needs solubilization as prerequisite for its complete removal from the tissue. Estimating residual proteins after decellularization has advantages over methods of measuring residual RNA and DNA content of the tissues. Complete removal of the filamentous nucleotides is achieved hardly without the use of DNAase or RNAase [1]. In principle, the use of enzymes during decellularization procedures for the production of bioscaffolds might lead to adverse immunological reactions in patients if they are not removed completely including the residuals and therefore limits their value in clinical applications. As seen in electron micrographs cellular and filamentous nuclear material was released from bursting cells by the deoxycholic acid treatment even in deep regions of the valve tissue. This aim in the preparation of bioscaffolds was accompanied now by the electron microscopic finding that the fine structure of the PG-associated interstitial network remained well preserved in the aortic heart valves during one or even two days of deoxycholic acid treatment. This was best seen in specimens selectively stained with CMB alone.

Preservation of the extracellular matrix with respect to the suitability of different decellularization techniques is also in the focus of other investigators [26–30]. The reason for this is that the mechanical properties of the scaffolds might not be sufficient if structures of the extracellular matrix are altered as it has been shown for trypsin-EDTA decellularized valves [28]. But on the other side incomplete decellularization leads to adverse immunological reactions [6]. Therefore it is now more and more accepted that detergent based decellularization techniques are preferable to other methods [31].

Previous work indicated that the extracellular matrix and its PGs play an important role in the development of cardiac valves [12] and therefore might be important for remodelling and growth of decellularized tissues [1]. Until now there is only limited information available whether and how decellularization techniques affect the distribution and structure of PGs and GAGs within the extracellular matrix of heart valves [28]. This study demonstrates that deoxycholic acid treatment of porcine aortic valves for up to 48 h does not affect the extracellular matrix architecture and its network of PGs inside the valves. Whether this is also true in porcine pulmonary valves and whether this is responsible for the observed remodelling and growth of the valves in vivo[7] needs further investigation. There is evidence that an intact extracellular matrix plays an important role in remodelling but less is known which co-factors are additionally required for the recellularization of bioscaffolds in vivo.

References

1. Erdbrügger W, Konertz W, Dohmen PM: Tissue Eng, 2006; 12; 2059-68, pmid: 16968148

2. Konertz W, Dohmen PM, Liu J, Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation: J Heart Valve Dis, 2005; 14; 78-81, pmid: 15700440

3. Bechtel JF, Stierle U, Sievers HH, Fifty-two months’ mean follow up of decellularized SynerGraft-treated pulmonary valve allografts: J Heart Valve Dis, 2008; 17; 98-104, pmid: 18365576

4. Dohmen PM, Lembcke A, Hotz H, Ross operation with a tissue-engineered heart valve: Ann Thorac Surg, 2002; 79; 1438-42, pmid: 12440590

5. da Costa F, Costa A, Prestes R, The early and midterm function of decellularized aortic valve allografts: Ann Thorac Surg, 2010; 90; 1854-60, pmid: 21095325

6. Simon P, Kasimir MT, Seebacher G, Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients: Eur J Cardiothorac Surg, 2003; 23; 1002-6, pmid: 12829079

7. Dohmen PM, da Costa F, Holinski S, Is there a possibility for a glutaraldehyde-free porcine heart valve to grow?: Eur Surg Res, 2006; 38; 54-61, pmid: 16490995

8. Dohmen PM, Lembcke A, Holinski S, Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure: Ann Thorac Surg, 2007; 84; 729-36, pmid: 17720368

9. Dohmen PM, Lembcke A, Holinski S, Ten years of clinical results with a tissue-engineered pulmonary valve: Ann Thorac Surg, 2011; 92; 1308-14, pmid: 21958777

10. Dohmen PM, Hauptmann S, Terytze A, Konertz W: J Heart Valve Dis, 2007; 16; 447-49, pmid: 17702372

11. Bloch O, Golde P, Dohmen PM, Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves: Tissue Eng Part A, 2011; 17; 2399-405, pmid: 21557643

12. Iwamoto R, Mine N, Kawaguchi T, HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans: Development, 2010; 137; 2205-14, pmid: 20530548

13. Grande-Allen KJ, Calabro A, Gupta V, Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordate: association with regions of tensile and compressive loading: Glycobiology, 2004; 14; 621-33, pmid: 15044391

14. Stephens EH, Chu C-K, Grande-Allen KJ, Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechincal load and age: Relevance to an age-specific tissue-engineenered heart valve: Acta Biomaterialia, 2008; 4; 1148-60, pmid: 18448399

15. Völker W, Schmidt A, Buddecke E, Compartmentation and characterizaton fo different proteoglycans in bovine arterial wall: J. Histochem Cytochem, 1986; 34; 1293-99, pmid: 2427568

16. Scott JE: J Anat, 1992; 180; 155-64, pmid: 1452471

17. Völker W, Strazynski M, Rothenburger M, Vischer P, Engineering of vascular tissue with a structurally organized extracellular matrix: Extending the Lifespan – Biotechnical, Gerontological, and Social Problems, 2005; 205-216, Germany, LIT Verlag Münster

18. Rothenburger M, Völker W, Vischer P, Ultrastructure of proteoglycans in tissue-engineered cardiovascular structures: Tissue Eng, 2002; 8; 1049-56, pmid: 12542950

19. Rothenburger M, Völker W, Vischer P, Tissue engineering of heart valves: formation of a three-dimensional tissue using porcine heart valve cells: ASAIO J, 2002; 48; 586-91, pmid: 12455767

20. Seligman AM, Wasserkrug HL, Hanker JS, A new staining method (OTO) for enhancing contrast of lipid-containing membranes and dropletes in osmium tetroxide-fixed tissue with osmiophilic thiocarbohydrazide (TCH): J Cell Biol, 1966; 30; 424-32, pmid: 4165523

21. Stephens EH, Chu CK, Grande-Allen KJ, Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve: Acta Biomater, 2008; 4; 1148-60, pmid: 18448399

22. Chen JH, Simmons CA, Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues: Circ Res, 2011; 108; 1510-24, pmid: 21659654

23. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding: Anal Biochem, 1976; 72; 248-54, pmid: 942051

24. Farndale RW, Buttle DJ, Barrett AJ, Impoved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylmethylen blue: Biochim Biophys Acta, 1986; 833; 173-77, pmid: 3091074

25. Grande-Allen KJ, Mako WJ, Calabro A, Loss of chondroitin 6-sulfate and hyaluronan from failed porcine bioprosthetic valves: J Biomed Mater Res A, 2003; 65; 2519

26. Arai S, Orton EC, Immunoblot detection of soluble protein antigens from sodium dodecyl sulfate- and sodium deoxycholate-treated candidate bioscaffold tissues: J Heart Valve Dis, 2009; 18; 439-43, pmid: 19852149

27. Kasimir MT, Rieder E, Seebacher G, Comparison of different decellularization procedures of porcine heart valves: Int J Artif Organs, 2003; 26; 421-27, pmid: 12828309

28. Schenke-Layland K, Vasilevski O, Opitz F, Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves: J Struct Biol, 2003; 143; 201-8, pmid: 14572475

29. Zhou J, Fritze O, Schleicher M, Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity: Biomaterials, 2010; 31; 2549-54, pmid: 20061016

30. Bastian F, Stelzmüller ME, Kratochwill K, IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue: Biomaterials, 2008; 29; 1824-32, pmid: 18258297

31. Tudorache I, Cebotari S, Sturz G, Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves: J Heart Valve Dis, 2007; 16; 567-73, pmid: 17944130

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750